Healthcare · Pharmaceuticals & Biotechnology
QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #69 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 12 Sep 2024 | GAGAN AGGARWAL | Key managerial personnel | Sell | 0 | ₹0 |
| 30 Jun 2023 | ATUL KUMAR CHAUBEY | Employee / designated person | Sell | 0 | ₹0 |
| 19 Jun 2023 | RAJESH NAG | Employee / designated person | Sell | 0 | ₹0 |
| 7 Jun 2023 | SATISH SHARMA | Employee / designated person | Sell | 0 | ₹0 |
| 5 Jun 2023 | LOVEKESH MAHAJAN | Employee / designated person | Sell | 0 | ₹0 |
| 3 Jun 2023 | LOVEKESH MAHAJAN | Employee / designated person | Sell | 0 | ₹0 |
| 1 Apr 2023 | Neha Verma | Immediate relative | Buy | 0 | ₹0 |
| 1 Dec 2022 | PRADEEP KUMAR GOEL | Employee / designated person | Sell | 0 | ₹0 |
| 30 Nov 2022 | PRADEEP KUMAR GOEL | Employee / designated person | Sell | 0 | ₹0 |
| 22 Sep 2022 | PRADEEP KUMAR GOEL | Other | Sell | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 29 May 2026 | HRTI PRIVATE LIMITED | Bulk | Sell | 202,663 | 153.0400 | NSE |
| 29 May 2026 | HRTI PRIVATE LIMITED | Bulk | Buy | 670,635 | 155.1000 | NSE |
| 20 Apr 2026 | HCP INVESTMENTS | Bulk | Sell | 700,000 | 131.1400 | BSE |
| 17 Apr 2026 | SHARE INDIA SECURITIES LIMITED | Bulk | Sell | 581,829 | 135.5300 | NSE |
| 17 Apr 2026 | SHARE INDIA SECURITIES LIMITED | Bulk | Buy | 689,971 | 134.2800 | NSE |
| 17 Apr 2026 | SAHASTRAA ADVISORS PRIVATE LIMITED | Bulk | Buy | 475,000 | 131.7400 | NSE |
| 17 Apr 2026 | PARTH INFIN BROKERS PVT LTD | Bulk | Sell | 465,673 | 131.8800 | NSE |
| 17 Apr 2026 | PARTH INFIN BROKERS PVT LTD | Bulk | Buy | 478,673 | 132.7600 | NSE |
| 17 Apr 2026 | NOVA GLOBAL OPPORTUNITIES FUND PCC - TOUCHSTONE | Bulk | Buy | 803,387 | 138.0700 | NSE |
| 17 Apr 2026 | MANSI SHARE AND STOCK BROKING PRIVATE LIMITED | Bulk | Buy | 798,784 | 132.6600 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 20 Sep 2011 | Annual General Meeting And Dividend Re.1/- Per Share | 1.0000 | — |
| 16 Sep 2010 | Annual General Meeting And Dividend Re.1/- Per Share | 1.0000 | — |
| 18 Sep 2008 | Agm/Dividend - 10% | — | — |
| 21 Sep 2007 | Agm/Dividend-10% | — | — |
| 22 Sep 2006 | Agm/Dividend-15% | — | — |
| 22 Sep 2005 | Agm/Dividend-15% | — | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| 24 Sep 2024 | OTHER | Annual General Meeting |
| 22 Sep 2023 | OTHER | Annual General Meeting |
| 22 Sep 2022 | OTHER | Annual General Meeting |
| 23 Sep 2021 | OTHER | Annual General Meeting |
| 23 Sep 2020 | OTHER | Annual General Meeting |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 10 Aug 2026 | Financial Results | Yes |
| 10 Jul 2026 | Fund Raising | — |
| 28 May 2026 | Financial Results | Yes |
| 31 Jan 2026 | Financial Results | Yes |
| 14 Nov 2025 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 30 Sep 2026 | AGM/EGM | Ind-Swift Laboratories Ltd - 532305 - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| 30 Sep 2026 | Shareholders meeting | Ind-Swift Laboratories Limited has informed the Exchange regarding Proceedings of 31st Annual General Meeting held on September 30, 2026. |
| 28 Sep 2026 | General Updates | Intimation to the shareholders of physical securities pursuant to SEBI Master Circular no. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 dated May 07, 2024 |
| 28 Sep 2026 | Trading Window | Ind-Swift Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 28 Sep 2026 | Insider Trading / SAST | Ind-Swift Laboratories Ltd - 532305 - Closure of Trading Window |
| 28 Sep 2026 | Company Update | Ind-Swift Laboratories Ltd - 532305 - Intimation To The Shareholders Of Physical Securities Pursuant To SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 Dated May 07, 2024 |
| 23 Sep 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Ind-Swift Laboratories Limited has informed the Exchange about Schedule of meet |
| 21 Sep 2026 | General Updates | Ind-Swift Laboratories Limited has informed the Exchange about Disclosures under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 |
| 21 Sep 2026 | Company Update | Ind-Swift Laboratories Ltd - 532305 - Disclosures Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011 |
| 17 Sep 2026 | Allotment of Securities | Ind-Swift Laboratories Limited has informed the Exchange regarding allotment of 70,00,000 Fully Convertible Warrants on Preferential Basis |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
